XML 59 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Stock Option Awards and Restricted Stock Grants (Details) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 2.23 $ 1.97
Weighted average contractual terms, exercisable 7 years 6 months  
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 441,425  
Weighted average exercise price, beginning balance $ 38.50  
Options outstanding, granted 697,156  
Weighted average exercise price, granted $ 2.79  
Options outstanding, Terminated (17,659)  
Weighted average exercise price, Terminated $ 35.28  
Options outstanding, ending balance 1,120,922  
Weighted average exercise price, ending balance $ 16.33  
Weighted average contractual terms 8 years 1 month 6 days  
Options outstanding, aggregate intrinsic value $ 335  
Options outstanding, exercisable 521,723  
Weighted average exercise price, exercisable $ 27.72  
Options outstanding, aggregate intrinsic value, exercisable  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 1,481  
Weighted average grant date fair value, beginning balance $ 12.36  
Non-vested stock awards, granted 55,650  
Weighted average grant date fair value, granted $ 1.96  
Non-vested stock awards, Terminated (100)  
Weighted average grant date fair value, Terminated $ 9.45  
Non-vested stock awards, ending balance 57,031  
Weighted average grant date fair value, ending balance $ 2.23  
Non-vested stock awards, aggregate intrinsic value